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EDITORIAL
Survival of Pancreatic Cancer
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Universitas Indonesia/Dr. Cipto Mangunkusumo General National Hospital, Jakarta
Pancreatic cancer is a highly aggressive cancer and 
has ranked the 12th most common cancer in the world. 
Pancreatic Cancer is increasing in the people of Asia 
Pacific including Indonesia.1,2 Pancreatic cancer is one 
of the deadliest cancer.1,2 The survival rate of pancreatic 
cancer is exceedingly low and short. The relative one 
year survival rate is only 24%, and the overall 5-year 
survival is about 6% (ranges from 2% to 9%).3,4 The 
case fatality rate for pancreatic cancer is approximately 
0.97 that has declined slightly (from 0.99 to 0.97) last 
12 years.3
Risk factors of pancreatic cancer are modifiable anc 
non-modifiavle risk factors. Modifiable risk factors 
include smoking, obesity, alcohol and dietary factors. 
Risk factors that are not modifiable include gender, age, 
family history of pancreatic cancer, genetic factors, 
diabetes mellitus, chronic pancreatitis and chronic 
infections.5,6,7
The most frequent type of pancreatic cancer is 
adenocarcinoma and variants (acount for 90%). 60-
70% of pancreatic adenocarcinomas arise in the head 
of the pancreas.7 Renaldi et al from their retrospective 
study found that 16% of their pancreatic cancer died 
within 2 months of follow up. This data showed that 
pancreatic cancer is a very dangerous and deadliest 
cancer, although this study recruited only small number 
of patients. This data also showed that the pancreatic 
cancer patients who came and admitted to the hospital 
were already in the advance and late stage. So this 
will remind us the need for early cancer screening 
and diagnosis to get a better survival of patients in 
Indonesia.8
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